• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELSOFT PLUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELSOFT PLUS Back to Search Results
Catalog Number 636006P
Device Problems Device Operates Differently Than Expected (2913); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  Injury  
Manufacturer Narrative
(b)(4).Method: actual device not evaluated - device was not returned to vascutek for analysis.Manufacturing review - manufacturing and qc records were reviewed.Results: no failure detected - manufacturing and qc records review showed that the device was manufactured to specification.Conclusion: off label, unapproved or contraindicated use - gelsoft plus is not indicated for thoracic use.A review of manufacturing and qc records confirmed that the device was manufactured to specification.Similar events review that covered polyester grafts for the past 5 years showed a very low occurrence rate of (b)(4) (complaints v sales).This is the first time vascutek received complaints for the graft elongation.There have been no similar complaints received from other units of the same batch.No negative trend in the number of complaints received was identified.Gelsoft plustm grafts are not indicated for carotid bypass use.As per ifu: gelsoft plustm are not recommended for thoracic use.Further action is not planned; however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.Vascutek consider this case closed.
 
Event Description
Vascutek ltd.Was notified of an event that occurred in (b)(6) in (b)(6) 2017, the event was described as follows: gelsoft plustm straight graft was used for carotid bypass.Implant occurred in (b)(6) 2016.The graft became elongated over time (1-year period) to the point it was beginning to erode through the skin.As a result, the graft was replaced ((b)(6) 2018).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSOFT PLUS
Type of Device
GELSOFT PLUS
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
carolyn forrest
newmains avenue
inchinnan business park
renfrewshire, PA4 9-RR
UK   PA4 9RR
MDR Report Key7525090
MDR Text Key108607582
Report Number9612515-2018-00006
Device Sequence Number1
Product Code DSY
UDI-Device Identifier05037881115023
UDI-Public05037881115023
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K955230
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Physician
Type of Report Initial
Report Date 04/19/2018,05/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/18/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date06/30/2021
Device Catalogue Number636006P
Device Lot Number386345-8987
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Device Age20 MO
Event Location Hospital
Date Report to Manufacturer04/19/2018
Date Manufacturer Received04/19/2018
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/07/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-